NCT00001649View on ClinicalTrials.gov

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 1997

Study Completion Date

August 31, 2003

Conditions
Herpes Simplex
Interventions
DRUG

Valaciclovir

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001649 - Valaciclovir to Prevent Transmission of Herpes Simplex Virus | Biotech Hunter | Biotech Hunter